Literature DB >> 18553154

Persistence of unmet need for care among people with systemic lupus erythematosus: a longitudinal study.

Neta Moses1, John Wiggers, Craig Nicholas.   

Abstract

PURPOSE: The extent and variability of unmet care needs over time of people with systemic lupus erythematosus (SLE) has not been previously reported. A prospective study was undertaken to determine the variability over time of such needs.
METHOD: A 97-item SLE needs questionnaire (SLENQ) was completed on two occasions 6 months apart by 233 members of a lupus support association. Levels of unmet need for each individual, and a mean symptom score were calculated.
RESULTS: Overall level of unmet need increased, decreased or stayed the same for 18%, 37%, and 45% of participants respectively. Ninety-four percent of participants at time 1 and 95% of participants at time 2 reported an unmet need for care for at least one item. The prevalence of unmet need for care remained the same for 82 of the 97 items. The mean unmet need score declined significantly between time 1 (0.78) and time 2 (0.69). The mean unmet need scores were significantly correlated with mean symptom score.
CONCLUSIONS: The results of the study suggest an unacceptable persistence of care needs not being met. There is an ongoing need to identify mechanisms to enhance care delivery so that the care needs of people with SLE are more effectively addressed.

Entities:  

Mesh:

Year:  2008        PMID: 18553154     DOI: 10.1007/s11136-008-9361-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  31 in total

1.  Classification and definition of major flares in SLE clinical trials.

Authors:  M Petri; J Buyon; M Kim
Journal:  Lupus       Date:  1999       Impact factor: 2.911

2.  Perceived learning needs of patients with coronary artery disease using a questionnaire assessment tool.

Authors:  M L Czar; M M Engler
Journal:  Heart Lung       Date:  1997 Mar-Apr       Impact factor: 2.210

Review 3.  How does one assess and monitor patients with systemic lupus erythematosus in daily clinical practice?

Authors:  Inam Haq; D A Isenberg
Journal:  Best Pract Res Clin Rheumatol       Date:  2002-04       Impact factor: 4.098

4.  Effect of environmental changes on oxidative deoxyribonucleic acid (DNA) damage in systemic lupus erythematosus.

Authors:  Etsuko Maeshima; Xiang-Ming Liang; Haruhisa Otani; Masatoshi Mune; Susumu Yukawa
Journal:  Arch Environ Health       Date:  2002 Sep-Oct

5.  The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being.

Authors:  P Panopalis; M Petri; S Manzi; D A Isenberg; C Gordon; J-L Senecal; J R Penrod; L Joseph; Y St Pierre; C Pineau; P R Fortin; N Sutcliffe; J-R Goulet; D Choquette; T Grodzicky; J M Esdaile; A E Clarke
Journal:  Rheumatology (Oxford)       Date:  2005-03-09       Impact factor: 7.580

6.  Systemic lupus erythematosus--a medical and social profile.

Authors:  H Stein; K Walters; A Dillon; M Schulzer
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

7.  Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study.

Authors:  M Petri; M Genovese; E Engle; M Hochberg
Journal:  Arthritis Rheum       Date:  1991-08

8.  Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.

Authors:  K M Uramoto; C J Michet; J Thumboo; J Sunku; W M O'Fallon; S E Gabriel
Journal:  Arthritis Rheum       Date:  1999-01

9.  Systemic lupus erythematosus in Australian aborigines: high prevalence, morbidity and mortality.

Authors:  N M Anstey; I Bastian; H Dunckley; B J Currie
Journal:  Aust N Z J Med       Date:  1993-12

10.  Quality of life over time in patients with systemic lupus erythematosus.

Authors:  Bindee Kuriya; Dafna D Gladman; Dominque Ibañez; Murray B Urowitz
Journal:  Arthritis Rheum       Date:  2008-02-15
View more
  8 in total

Review 1.  Non-pharmacologic therapies for systemic lupus erythematosus.

Authors:  M Fangtham; S Kasturi; R R Bannuru; J L Nash; C Wang
Journal:  Lupus       Date:  2019-04-08       Impact factor: 2.911

2.  Impact of the Affordable Care Act Medicaid Expansion on Access to Care and Hospitalization Charges for Lupus Patients.

Authors:  Elizabeth A Brown; Clara E Dismuke-Greer; Viswanathan Ramakrishnan; Trevor D Faith; Edith M Williams
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-02       Impact factor: 4.794

3.  Patient-Reported Outcomes Predict Mortality in Lupus.

Authors:  Desiree R Azizoddin; Meenakshi Jolly; Shilpa Arora; Ed Yelin; Patricia Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-07-13       Impact factor: 4.794

4.  Health care in systemic lupus erythematosus (SLE): the patient's perspective.

Authors:  E J M Zirkzee; G M Steup-Beekman; A A Schouffoer; S M Henquet; M A A Caljouw; T W J Huizinga; T P M Vliet Vlieland
Journal:  Clin Rheumatol       Date:  2014-04-18       Impact factor: 2.980

5.  Living with invisible illness: social support experiences of individuals with systemic lupus erythematosus.

Authors:  Kirby A M Brennan; Ann-Marie Creaven
Journal:  Qual Life Res       Date:  2015-10-08       Impact factor: 4.147

6.  The Lived Experience of Lupus Flares: Features, Triggers, and Management in an Australian Female Cohort.

Authors:  Marline L Squance; Glenn E M Reeves; Howard Bridgman
Journal:  Int J Chronic Dis       Date:  2014-11-20

7.  Variation in pain related to systemic lupus erythematosus (SLE): a 7-year follow-up study.

Authors:  Eva Waldheim; Sofia Ajeganova; Stefan Bergman; Johan Frostegård; Elisabet Welin
Journal:  Clin Rheumatol       Date:  2018-04-14       Impact factor: 2.980

8.  Impaired hand function and performance in activities of daily living in systemic lupus erythematosus, even in patients achieving lupus low disease activity state (LLDAS).

Authors:  Kyriaki Keramiotou; Christos Anagnostou; George Konstantonis; Evangelia Kataxaki; Petros P Sfikakis; Maria G Tektonidou
Journal:  Rheumatol Adv Pract       Date:  2021-05-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.